The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin

被引：0
|
作者：
Xenocostas, A
Cheung, W
Zakszewski, C
Kelly, M
Lutynski, A
Crump, M
Lipton, J
Kiss, T
Messner, H
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
EXPERIMENTAL HEMATOLOGY | 2002年 / 30卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
21
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [31] The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates
    Fox, Elizabeth
    Jayaprakash, Nalini
    Pham, Tuyet-Hang
    Rowley, Ayana
    McCully, Cynthia L.
    Pucino, Frank
    Goldbach-Mansky, Raphaela
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 223 (1-2) : 138 - 140
  • [32] Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates
    Stacie L. Stapleton
    Joel M. Reid
    Patrick A. Thompson
    Matthew M. Ames
    Renee M. McGovern
    Leticia McGuffey
    Jed Nuchtern
    Robert Dauser
    Susan M. Blaney
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 461 - 466
  • [33] The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates
    Kim, AeRang
    McCully, Cindy
    Cruz, Rafael
    Cole, Diane E.
    Fox, Elizabeth
    Balis, Frank M.
    Widemann, Brigitte C.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 524 - 528
  • [34] The plasma and cerebrospinal fluid pharmacokinetics of satraplatin after intravenous administration in non-human primates
    Marcus, Leigh J.
    Murphy, Robert F.
    Fox, Elizabeth
    McCully, Cynthia L.
    Cruz, Rafeal
    Warren, Kathy
    Balis, Frank M.
    Widemann, Brigitte C.
    Meyer, Thorsten
    CANCER RESEARCH, 2010, 70
  • [35] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CHRONIC-HEMODIALYSIS
    BARNAS, U
    WATZINGER, U
    PEER, G
    MAYER, G
    GRAF, H
    NEFROLOGIA, 1990, 10 : 116 - 120
  • [36] INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON HEMODIALYSIS AND CAPD
    EIDEMAK, I
    FRIEDBERG, MO
    LADEFOGED, SD
    LOKKEGAARD, H
    PEDERSEN, E
    SKIELBOE, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (06) : 526 - 529
  • [37] SUBCUTANEOUS VERSUS INTRAVENOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTRATION IN HEMODIALYSIS-PATIENTS
    BORAN, M
    DALVA, I
    YAZICIOGLU, A
    CETIN, S
    NEPHRON, 1993, 63 (01) : 113 - 114
  • [38] INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) IN PREDIALYSIS CHILDREN
    NAVARRO, M
    ALONSO, A
    MUNOZ, I
    GONZALEZ, M
    MESEGUER, CG
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1402 - 1403
  • [39] RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA IN DIALYSIS PATIENTS - COMPARISON OF INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION
    ZEHNDER, C
    BLUMBERG, A
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 120 (07) : 217 - 220
  • [40] Pure Red Cell Aplasia Induced Only by Intravenous Administration of Recombinant Human Erythropoietin
    Shimizu, Hiroaki
    Saitoh, Takayuki
    Ota, Fumie
    Jimbo, Takahiro
    Tsukada, Yoshito
    Murakami, Hirokazu
    Nojima, Yoshihisa
    ACTA HAEMATOLOGICA, 2011, 126 (02) : 114 - 118
12345